Home
>
National Drug Code (NDC)
>
Methotrexate
Methotrexate - 63323-122-50 - (METHOTREXATE SODIUM)
Drug Information of Methotrexate
| Product NDC: | 63323-122 |
| Proprietary Name: | Methotrexate |
| Non Proprietary Name: | METHOTREXATE SODIUM |
| Active Ingredient(s): | 1 g/1 & nbsp; METHOTREXATE SODIUM |
| Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate
| Product NDC: | 63323-122 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040266 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000122 |
Package Information of Methotrexate
| Package NDC: | 63323-122-50 |
| Package Description: | 1 VIAL in 1 CARTON (63323-122-50) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Information of Methotrexate
| NDC Code | 63323-122-50 |
| Proprietary Name | Methotrexate |
| Package Description | 1 VIAL in 1 CARTON (63323-122-50) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 63323-122 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METHOTREXATE SODIUM |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Start Marketing Date | 20000122 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
